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Abstract 
Review on Renal papillary adenoma, with data on 
clinics, and the genes involved. 
Keywords 
Renal papillary adenoma 
Identity 
Other names 
Renal papillary adenoma, Tubulo-papillary adenoma 
Note 
Papillary adenomas are benign renal tumors that are, 
based on the 2016 WHO classification of renal 
tumors, low grade papillary neoplasms that are 
15mm or fewer in diameter (Moch et al., 2016). This 
defining size for papillary adenoma was increased 
from 5mm in the prior WHO classification as 
metastases from these tumors are not observed in 
lesions that are ≤15mm. 
Phylum 
Urinary 
system:Kidney:Adult:Adenoma:Tubulopapillary 
adenoma 
Clinics and pathology 
Disease 
Renal papillary adenoma 
Epidemiology 
Papillary adenomas are common. They have been 
reported in 7% of nephrectomy specimens and 10-
40% of autopsy kidneys. In autopsy series, the 
lesions are more common in older patients (10% of 
patients 70 years) and in patients with end stage 
kidney disease. Papillary adenomas may be found 
more frequently in resected kidneys with papillary 
renal cell carcinoma, and in patients with hereditary 
RCC, renal vascular disease, end-stage renal disease 
or acquired cystic kidney disease. 
Clinics 
Most renal papillary adenomas are discovered 
incidentally at nephrectomy for another disease. 
However, with better imaging more tumors may be 
identified preoperatively. Multiple, bilateral 
papillary adenomas are referred to as renal 
adenomatosis. 
Pathology 
The current World Health Organization (WHO) 
classification of kidney tumors defines renal 
papillary adenomas as unencapsulated epithelial 
tumors lesions with a tubulo-papillary architecture 
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measuring ≤ 15mm and of low nuclear grade (Eble 
et al., 2016). The tumors morphologically resemble 
PRCC with papillary to tubulopapillary architecture 
and CK7 expression. By definition, cytologic aypia 
and necrosis are absent (Fig. 1). 
 
 Figure 1:   Histologically, papillary adenomas resemble low grade papillary RCC, but are < 15 mm in greatest dimension. 
Treatment 
Although very little is typically done for small renal 
masses <2.0 cm, a core biopsy can be obtained to 
confirm the diagnosis of a papillary adenoma 
detected by imaging.  Subsequent treatment options 
would typically include observation and 
cyoablation; surgery is less for papillary adenomas 
and is typically reserved for carcinomas. 
Evolution 
It has been proposed that renal papillary adenomas 
are precursor lesions of papillary renal cell 
carcinoma. In addition to the epidemiologic 
association with PRCC (see above), papillary 
adenomas and PRCC show similar 
immunohistochemical expression of alpha-
methylacyl-coenzyme A racemase ( AMACR ). 
Interestingly, papillary adenomas arising in the 
setting of acquired polycystic kidney disease do not 
show AMACR expression, suggesting a different 
biological mechanism for these neoplasms. 
Prognosis 
Excellent for this benign lesion. Renal papillary 
adenomas theoretically have no metastatic potential. 
Cytogenetics 
Note 
Trisomy 7 and 17, and loss of the Y chromosome are 
common changes in papillary adenomas.There are 
no definitive cytogenetic differences between the 
small tumors classified as adenomas and PRCC. 
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